ETrade Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $768K | Sell |
12,772
-599
| -4% | -$36K | 0.01% | 452 |
|
|
2020
Q2 | $702K | Sell |
13,371
-384
| -3% | -$20.2K | 0.01% | 464 |
|
|
2020
Q1 | $461K | Sell |
13,755
-766
| -5% | -$25.7K | 0.01% | 490 |
|
|
2019
Q4 | $658K | Buy |
14,521
+7,291
| +101% | +$330K | 0.01% | 481 |
|
|
2019
Q3 | $275K | Buy |
7,230
+155
| +2% | +$5.9K | 0.01% | 698 |
|
|
2019
Q2 | $308K | Sell |
7,075
-572
| -7% | -$24.9K | 0.01% | 679 |
|
|
2019
Q1 | $291K | Buy |
+7,647
| New | +$291K | 0.01% | 685 |
|
|
2017
Q4 | – | Sell |
-10,664
| Closed | -$400K | – | 759 |
|
|
2017
Q3 | $400K | Buy |
10,664
+846
| +9% | +$31.7K | 0.01% | 525 |
|
|
2017
Q2 | $468K | Sell |
9,818
-2,802
| -22% | -$134K | 0.02% | 471 |
|
|
2017
Q1 | $575K | Buy |
+12,620
| New | +$575K | 0.02% | 406 |
|